Human-specific neoantigen receptor T cells and neoantigen receptor B cells

Immune clearance with a variety of new antigen-producing organisms variant cell populations, tumor tissue, cancer cell populations and their derivatives and infection sources and other causes without accidentally injuring any normal cells/tissues/organs/systems of the two categories of "immune cell forces"

Polyclonal antibodies against neoantigen-producing organisms

Immunization to kill various mutant cells with new antigen-producing organisms, including cancer cells and their derivatives and infected cells, without accidentally injuring any normal cells "immunoglobulin multiple forces"